Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Common Equity (2018 - 2025)

Zai Lab's Common Equity history spans 8 years, with the latest figure at $715.5 million for Q4 2025.

  • For Q4 2025, Common Equity fell 14.91% year-over-year to $715.5 million; the TTM value through Dec 2025 reached $715.5 million, down 14.91%, while the annual FY2025 figure was $715.5 million, 14.91% down from the prior year.
  • Common Equity for Q4 2025 was $715.5 million at Zai Lab, down from $759.9 million in the prior quarter.
  • Across five years, Common Equity topped out at $1.7 billion in Q2 2021 and bottomed at $667.7 million in Q3 2024.
  • The 5-year median for Common Equity is $906.6 million (2023), against an average of $999.2 million.
  • The largest annual shift saw Common Equity soared 259.15% in 2021 before it crashed 30.36% in 2022.
  • A 5-year view of Common Equity shows it stood at $1.4 billion in 2021, then dropped by 24.23% to $1.0 billion in 2022, then decreased by 23.86% to $796.1 million in 2023, then rose by 5.62% to $840.9 million in 2024, then decreased by 14.91% to $715.5 million in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's Common Equity are $715.5 million (Q4 2025), $759.9 million (Q3 2025), and $791.7 million (Q2 2025).